Home › Phases › NDA Submitted

NDA Submitted (21 companies)

Companies with at least one active program at NDA Submitted.

Ticker	Company	Therapeutic areas	NDA Submitted programs	Lead stage	Programs
ALDX	Aldeyra Therapeutics, Inc.	DermatologyOncologyOphthalmology Rare	1	NDA Submitted	8
ANNX	Annexon, Inc.	HematologyNeurologyOphthalmologyRenal Rare	1	NDA Submitted	6
CLRB	Cellectar Biosciences, Inc.	Oncology	1	NDA Submitted	11
CGON	CG Oncology, Inc.	Oncology	1	NDA Submitted	1
CLNN	Clene Inc.	Neurology Rare	1	NDA Submitted	5
COGT	Cogent Biosciences, Inc.	HematologyOncology Rare	2	NDA Submitted	7
CMPS	COMPASS Pathways plc	Neurology	1	NDA Submitted	3
CGEM	Cullinan Therapeutics, Inc.	ImmunologyOncology	1	NDA Submitted	7
DBVT	DBV Technologies S.A.	GI/HepatologyImmunology Rare	1	NDA Submitted	3
ETON	Eton Pharmaceuticals, Inc.	GI/HepatologyMetabolicRenal Rare	1	Approved	14
EXEL	EXELIXIS, INC.	Oncology	1	NDA Submitted	2
IBRX	ImmunityBio, Inc.	Infectious DiseaseOncology	1	Approved	17
NTLA	Intellia Therapeutics, Inc.	CardiovascularImmunology Rare	1	NDA Submitted	5
KYTX	Kyverna Therapeutics, Inc.	ImmunologyNeurologyRenal Rare	1	NDA Submitted	7
NRXP	NRX Pharmaceuticals, Inc.	Neurology	2	NDA Submitted	5
OMER	OMEROS CORP	HematologyNeurologyOncologyRespiratory Rare	1	NDA Submitted	7
RYTM	RHYTHM PHARMACEUTICALS, INC.	Metabolic Rare	1	Approved	13
RARE	Ultragenyx Pharmaceutical Inc.	CardiovascularGI/HepatologyMetabolicNeurology Rare	2	Approved	12
VNDA	Vanda Pharmaceuticals Inc.	CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare	4	Approved	26
VERA	Vera Therapeutics, Inc.	Infectious DiseaseRenal Rare	1	NDA Submitted	8
VRDN	Viridian Therapeutics, Inc.\DE	Ophthalmology	1	NDA Submitted	6